Psychological well-being declines years before diagnosis of MCI
Aug 20, 2024
The findings were seen specifically for the components of purpose in life and personal growth.
Pfizer plans to charge more than $100 per COVID-19 shot in 2023
Oct 24, 2022
People with Medicare or Medicaid and those with private health insurance likely would get the vaccine for free.
FDA delays decision on new Alzheimer’s drug
Mar 08, 2024
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Company hid problems with COVID-19 vaccines from FDA
May 10, 2022
Nearly 400 million doses of vaccine made by Emergent had to be destroyed “due to poor quality control.”
New Sanofi-GSK COVID-19 vaccine highly effective, companies say
Feb 23, 2022
In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine.
New COVID-19 drug guards against all variants in immunocompromised
Apr 28, 2023
The trial results could be out by September and may lead to the FDA emergency use authorization.
In early trial, results promising for Moderna combo COVID-flu vaccine
Oct 05, 2023
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025.
Pfizer says omicron-specific vaccine ready by March
Jan 12, 2022
Pfizer also is working to improve its current COVID-19 vaccine “to address any future variant of potential concern, if needed.”
CDC could loosen indoor mask mandates as early as next week
Feb 16, 2022
The White House has been eager for the CDC to provide an update on its indoor mask recommendation.